User menu

Guidelines for the labelling of leucocytes with Tc-99m-HMPAO

Bibliographic reference de Vries, Erik F. J. ; Roca, Manel ; Jamar, François ; Israel, Ora ; Signore, Alberto. Guidelines for the labelling of leucocytes with Tc-99m-HMPAO. In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 37, no. 4, p. 842-8 (2010)
Permanent URL http://hdl.handle.net/2078.1/33635
  1. Guidelines on current good radiopharmacy practice (cGRPP) in the preparation of radiopharmaceuticals. EANM Radiopharmacy committee. Eur J Nucl Med Mol Imaging 2009 (in press), https://www.eanm.org/scientific_info/guidelines/gl_radioph_cgrpp.pdf
  2. Ak I, Vardereli E, Durak B, Gülbaş Z, Basaran N, Stokkel MPM, et al. Labeling of mixed leukocytes with 99mTc-HMPAO causes severe chromosomal aberrations in lymphocytes. J Nucl Med 2002;43:203–6.
  3. Annovazzi A, Bagni B, Burroni L, D′Alessandria C, Signore A. Nuclear medicine imaging of inflammatory/infective disorders of the abdomen. Nucl Med Commun 2005;26:657–64.
  4. Capriotti G, Chianelli M, Signore A. Nuclear medicine imaging of diabetic foot infection: results of meta-analysis. Nucl Med Commun 2006;27:757–64.
  5. Cascini GL, De Palma D, Matteucci F, Biggi A, Rambaldi PF, Signore A, et al. Fever of unknown origin, infection of subcutaneous devices, brain abscesses and endocarditis. Nucl Med Commun 2006;27:213–22.
  6. Danpure HJ, Osman S. A review of methods of separating and radiolabelling human leucocytes. Nucl Med Commun 1988;9:681–5.
  7. Danpure HJ, Osman S, Carroll MJ. The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oxime. Nucl Med Commun 1988;9:465–75.
  8. Jacquier-Sarlins MR, Polla BS, Slosman DO. Oxido-reductive state: the major determinant for cellular retention of technetium-99m-HMPAO. J Nucl Med 1996;37:1413–6.
  9. Morrissey GJ, Powe JE. Routine application of fractional HMPAO stored at -70C for WBC scintigraphy. J Nucl Med 1993;34:151–5.
  10. Palestro CJ, Brown ML, Forstrom LA, Greenspan BS, McAfee JG, Royal HD, Schauwecker DS, Seabold JE, Signore A. Society of Nuclear Medicine Procedure Guideline for 99mTc-exametazime (HMPAO)-labeled leukocyte scintigraphy for suspected infection/inflammation, version 3.0, 2004, http://interactive.snm.org/docs/HMPAO_v3.pdf
  11. Peters AM, Osman S, Henderson BL, Kelly JD, Danpure HJ, Hawker RJ, et al. Clinical experience with 99mTc-hexamethylpropyleneamineoxime for labelling leukocytes and imaging inflammation. Lancet 1986;8513:946–9.
  12. Prandini N, Lazzeri E, Rossi B, Erba P, Parisella MG, Signore A. Nuclear medicine imaging of bone infections. Nucl Med Commun 2006;27:633–44.
  13. Roca M, Martín-Comín J, Becker W, Bernardo-Filho M, Gutfilen B, Moisan A, et al. A consensus protocol for white blood cell labelling with technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1998;25:797–9.
  14. Roddie M E, Peters A M, Danpure H J, Osman S, Henderson B L, Lavender J P, Carroll M J, Neirinckx R D, Kelly J D, Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes., 10.1148/radiology.166.3.3340775
  15. Sampson CB, Solanki C, Barber RW. 99Tcm-exametazime-labelled leucocytes: effect of volume and concentration of exametazime on labelling efficiency, and clinical protocol for high efficiency multi-dose radiolabelling. Nucl Med Commun 1991;12:719–23.
  16. Saverymuttu S. H., Peters A. M., Danpure H. J., Reavy H. J., Osman S., Lavender J. P., Lung Transit of 111Indium-Labelled Granulocytes : Relationship to Labelling Techniques, 10.1111/j.1600-0609.1983.tb01463.x
  17. Solanki KK, Mather SJ, Al Janabi M, Britton KE. A rapid method for the preparation of 99Tcm hexametazime-labelled leucocytes. Nucl Med Commun 1988;9:753–61.
  18. Suess E, Huck S, Reither H, Hörtnagl H, Angelberger P. Uptake mechanism of technetium-99m-d, 1-HMPAO in cell cultures of the dissociated postnatal rat cerebellum. J Nucl Med 1992;33:108–14.
  19. Thierens HMA, Vral AM, Van Haelst JP, Van de Wiele C, Schelstraete KHG, de Ridder LIF. Lymphocyte labeling with technetium-99m-HMPAO: a radiotoxicity study using the micronucleus assay. J Nucl Med 1992;33:1167–74.
  20. Piera C., Vázquez A., Hernández M.A., Plancha M.C., Ruiz A., Mateos J.J., Martín F., Ortega M.L., Fuertes S., Pons F., Método rápido de marcaje de leucocitos con 99mTc HM-PAO, 10.1016/s0212-6982(02)72105-8
  21. UK Radiopharmacy Group. Guidelines for the safe preparation of radiolabelled blood cells. http://www.ukrg.org.uk/
  22. Yeo C, Saunders N, Locca D, Flett A, Preston M, Brookman P, et al. Ficoll-Paque versus Lymphoprep: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations. Regen Med 2009;4:689–96.